Cytokinetics CYTK
NASDAQ CYTK
$58.54 +2.36 (+4.20%)
As of: Nov 11, 2026 · 3:59 PM EST

Cytokinetics (CYTK) Cash & Current Investments (2009 - 2026)

Updated

Cytokinetics (CYTK) reported Cash & Current Investments of $1.13 billion for Q3 2026, up 17.4% from $962.54 million a year earlier but down 3.1% from the prior quarter.

Analysis

Cytokinetics (CYTK) Cash & Current Investments (2009 - 2026) Analysis & Trends

At the end of FY2025, Cytokinetics posted Cash & Current Investments of $882.22 million, down 18.0% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 13.7% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $1.08 billion in FY2024 (+75.0%), $615.2 million in FY2023 (-21.5%), $784.18 million in FY2022 (+66.3%) and $471.64 million in FY2021 (+1.6%).
  • Five-year quarterly Cash & Current Investments spans a low of $471.64 million in Q4 2021 and a high of $1.17 billion in Q2 2026.
  • Year over year, Cash & Current Investments gained in four of the last eight quarters, with growth averaging 15.6%.
  • The high point for year-over-year Cash & Current Investments in five years was Q3 2024 (growth of 87.6%); the low point was Q3 2023 (a decline of 37.8%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $1.17 billion (Q2 2026), $818.55 million (Q1 2026) and $882.22 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.23 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 505.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 14.27 Bn
10 Cytokinetics 7.83 Bn 3.24 Bn 47.10 Mn 1.13 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1.13 Bn
Jun 30, 2026 1.17 Bn
Mar 31, 2026 1.07 Bn
Dec 31, 2025 1.22 Bn
Sep 30, 2025 1.25 Bn
Jun 30, 2025 1.04 Bn
Mar 31, 2025 938.59 Mn
Dec 31, 2024 1.22 Bn
Sep 30, 2024 1.28 Bn
Jun 30, 2024 1.06 Bn
Mar 31, 2024 634,337.00
Dec 31, 2023 655.36 Mn
Sep 30, 2023 554.71 Mn
Jun 30, 2023 -111,775.00
Mar 31, 2023 704,368.00
Dec 31, 2022 829.29 Mn
Sep 30, 2022 299,514.00
Jun 30, 2022 -89,363.00
Mar 31, 2022 686,057.00
Dec 31, 2021 623.69 Mn
API Access

Cytokinetics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CYTK&period=max&api_key=YOUR_API_KEY